A new study found that cystic fibrosis patients with more severe disease characteristics exhibit shorter leukocyte telomere length and greater LTL attrition. This association may accelerate aging and increase susceptibility to age-related diseases, emphasizing the importance of early CF diagnosis and timely therapeutic intervention.
A new preclinical blood test identifies adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD), by analyzing 32 proteins that accurately predict lung health data. The risk score indicates a high likelihood of hospital care, COPD development, and respiratory disease death.
A pilot study found that voice changes recorded on a smartphone can signal an impending flare-up of COPD symptoms. Researchers analyzed the voices of 28 people with COPD and discovered higher pitched tones and 'jitter' before an exacerbation occurred.
Two studies found that long-term exposure to air pollution increases the risk of hospitalization for respiratory conditions, including asthma and COPD. Green spaces may actually increase emergency room visits for respiratory issues when combined with hay fever.
A new smart mask prototype, EBCare, analyzes chemicals in exhaled breath in real-time, offering personalized health monitoring for respiratory ailments like asthma and COPD. The device's self-cooling system allows for daily wear, while its low cost makes it a promising tool for remote health assessments.
Inhalation of live Lactobacilli bacteria attenuates pulmonary inflammation, improves lung function, and structure for COPD and bronchopulmonary dysplasia. The treatment reduces neutrophilic inflammation, MMP-9, and pro-inflammatory markers.
A recent study found that approximately two-thirds of inhalers used by patients hospitalized with COPD were misused, leading to inadequate medication delivery and increased exacerbations. Regular therapeutic education and proper inhaler technique can improve health outcomes.
A new perspective article highlights the impact of wildfires on individuals with COPD and asthma. The five-part Population Health Approach, developed by the University of California, Davis Health, identifies high-risk patients and provides interventions to mitigate poor air quality's negative effects.
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed with the Directory of Open Access Journals (DOAJ), enhancing their open access content's accessibility and usage. The indexation is attributed to strong editorial boards led by Hayley Gershengorn and Matthew Miles.
A new study found that using race-neutral equations for lung function test interpretation accurately predicted risk of death and COPD flare-ups, especially for African Americans. The study suggests reclassifications can allow those most in need to gain eligibility for specialized treatments like lung transplant.
Researchers report that dupilumab substantially decreases exacerbation frequency and improves lung function as well as symptom burden in COPD patients with type 2 inflammation. The study's findings are promising for these patients, who have a high risk of exacerbations.
Treatment with bisoprolol did not reduce self-reported COPD exacerbations, contradicting previous expectations. Researchers found bisoprolol effective for cardiovascular conditions but noted physician reluctance to prescribe it for COPD patients.
A world-first clinical trial found that finding and treating people with undiagnosed asthma or COPD improves their health and reduces healthcare visits. The study, which involved 508 patients, showed that those treated by a lung specialist and educator averaged fewer healthcare visits and improved symptoms compared to usual care.
Research found that race-neutral spirometry equations tend to decrease severity for white patients and increase severity for Black patients, leading to higher enrollment rates of Black patients in COPD clinical trials. This shift resulted in more Black subjects meeting typical inclusion criteria, while fewer white subjects were eligible.
Researchers developed CT-Derived Functional Imaging, a software program that calculates lung volume changes and blood mass without contrast dye. The technology has improved diagnoses for up to 30% of patients who couldn't tolerate contrast dye, and also benefits all patients with lung issues such as COPD and cancer.
A new study found that progressive lung abnormalities in smokers are associated with increased frequency and severity of acute respiratory diseases, highlighting the need for closer monitoring and earlier intervention.
The Lundquist Institute has been awarded a four-year, $2.6 million grant to develop wearable multiplex biosensors that can monitor exacerbation risk in COPD. The proposed sensors have the potential to revolutionize COPD management and transform chronic disease management by providing real-time, non-invasive monitoring.
Researchers found that patients with lung disease have a higher risk of developing heart disease, regardless of age or smoking status. The study, published in Orphanet Journal of Rare Diseases, suggests that Proteinase 3 enzyme may play a key role in this increased risk.
Researchers found that Indigenous communities in California were exposed to 1.7 times more wildfire smoke than expected, with the average annual exposure being a critical factor in understanding long-term health effects. The study proposes new metrics to measure cumulative exposure and duration of smoke exposure.
Research published in Thorax found a link between age of menarche and increased COPD risk, with early menarche increasing the risk by 17%. Women who experienced infertility or had multiple miscarriages were also at higher risk. Menopause before age 40 was associated with a significant increase in COPD risk.
Cadmium exposure from cigarette smoke can lead to increased ANO1 expression in airway epithelial cells, exacerbating COPD. MicroRNA-381 negatively regulates ANO1, but its downregulation by cadmium could worsen disease severity.
A new study by the University of Technology Sydney suggests that office air conditioning can reduce the risk of harm from wildfire smoke. The researchers found that air conditioning filters in UTS Buildings 4 and 7 captured a significant portion of wildfire smoke, reducing exposure to toxic particles for staff and students.
Researchers found that a team intervention provided by phone leads to persistent improvements in depression, anxiety, and quality of life for people managing chronic illnesses. The program demonstrated early, persistent, and clinically meaningful improvements in adults with COPD, HF, or ILD.
A clinical trial found that trazodone and cognitive behavioral therapy for insomnia were no more effective than placebo in improving insomnia symptoms among long-term dialysis patients. Serious adverse events also occurred more frequently with trazodone use. More trials are needed to investigate additional therapies for this condition.
A new study reveals that bacteria associated with gum disease promote COPD through the activation of γδ T cells and M2 macrophages in the immune system. Researchers found that mice infected with periodontitis and COPD had worse progression, highlighting a potential new strategy for treating COPD.
The ATS 2024 International Conference in San Diego will feature scientific sessions and expert interviews on the latest developments in pulmonary, critical care, and sleep medicine. The conference will cover key subjects such as COVID-19, asthma, COPD, and air pollution.
A ground-breaking study published in Nature Communications sheds light on the intricate mechanisms underlying the virulence of Aspergillus fumigatus, specifically focusing on the crucial role of mycotoxin gliotoxin production. The research team identified pivotal roles played by GliT oxidoreductase and GtmA methyltransferase in the sel...
Researchers identified Benidipine as a compound promoting the death of cigarette smoke-induced senescent lung cells, improving lung emphysema. The dihydropyridine family of calcium channel blockers constitutes a new class of senolytics that could improve lung diseases.
A 12-week beetroot juice supplement reduced systolic blood pressure by 4.5mmHg and increased walking distance by 30 meters in COPD patients. The nitrate-rich supplement improved cardiovascular risk markers, suggesting potential benefits for everyday life and heart disease prevention.
The November issue of CHEST journal features cutting-edge research on asthma, COPD, diffuse lung disease, and thoracic oncology. A new guideline provides updated recommendations for patients with stable COPD, while home spirometry is shown to be less consistent than clinic spirometry in monitoring lung function in patients with asthma.
Researchers at Brigham and Women's Hospital analyzed data from over 7,500 patients to discover that suspected bronchiectasis in smokers is associated with a higher risk of mortality. The study suggests that lung imaging can help identify this condition, leading to improved patient care.
The Center for Advancing Point of Care Technologies (CAPCaT) has received a five-year, $8.9 million award from the NIH to develop innovative point-of-care health technologies. The program aims to address heart, lung, blood and sleep disorders in underserved populations.
A study of hospitalized adults with new-onset atrial fibrillation found that 1 in 3 patients experienced a recurrent episode of AF within a year. This rate is approximately 7 times higher than in matched control participants, suggesting that oral anticoagulation therapy may be warranted for these patients.
A new study found that older adults with COPD had a heightened risk of depression during the early stages of the COVID-19 pandemic. Approximately 1 in 2 individuals with COPD and a pre-pandemic history of depression experienced a recurrence of depression.
The September issue of the CHEST journal features research on long COVID, including a review on exercise pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2. Original studies also explore asthma treatment with albuterol-budesonide inhalers and sleep therapy using oronasal masks.
A phase I clinical trial shows that transplanting P63+ lung progenitor cells can repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD), improving breathing and quality of life. The treatment increased lung function, reduced symptoms, and even repaired mild emphysema in some patients.
Annual COPD hospital admissions in Canada increased substantially between 2002 and 2017, with a notable rise in females and younger adults. The number of hospital admissions for COPD has rapidly increased since 2010, suggesting that progress may not be being made in improving COPD care and outcomes.
Research found that women exposed to air pollution give birth to smaller babies, with PM2.5 and other pollutants associated with average reductions in birth weight. However, living in greener areas was linked to slightly higher birth weights, suggesting a potential mitigation effect.
People with asthma and COPD face increased breathing difficulties due to climate change's effects on heatwaves, wildfires, and flooding. Experts urge governments to reduce greenhouse gas emissions to mitigate these risks.
The August issue of CHEST journal features a new clinical practice guideline for managing patients with neuromuscular weakness and a multisociety evidence review on the effect of race and ethnicity on pulmonary function testing interpretation. This is complemented by other research and reviews covering various aspects of chest medicine.
A new imaging method developed by UC researchers can identify specific lung infections in real time, reducing diagnosis time from 2-3 days to hours. The method uses injectable probes that light up under a nuclear imaging machine, enabling faster treatment for critically ill patients.
A large study published in ERJ Open Research found that people with low levels of vitamin K in their blood are more likely to have poor lung function and experience respiratory issues. The research suggests that vitamin K may play a role in keeping lungs healthy, but further studies are needed to confirm this link.
A recent study published in Annals of Internal Medicine found that continued breast cancer screening after age 70 is associated with a greater incidence of cancer that likely would not have caused symptoms. Researchers estimate up to 47% of breast cancers found among women aged 74-84 were overdiagnosed.
A new study by UCSF found that half of participants with extensive tobacco exposure had persistently high respiratory symptoms, yet performed well in COPD tests. The study highlights a gap in effective care for tobacco-exposed individuals and emphasizes the need for broader definition of smoking-related lung disease.
The July issue of CHEST journal features 49 articles on clinically relevant topics, including disability rights and life-sustaining treatment. The journal offers complementary web resources, such as visual abstracts, to expand the reach of its research.
A new paper-based device combines microfluidics and electrochemical transduction to detect inflammation biomarkers in sputum samples. This compact device can simultaneously measure three biomarkers, including IL-8, TNF-α, and MPO, for early COPD detection.
Current diagnosis of COPD using fixed-ratio spirometry may fail to diagnose the disease in African American patients due to flawed methods. The study found that 21% more results for African Americans were classified as non-COPD, despite showing clear symptoms of COPD.
An epigenetic study of over 18,000 people in Scotland identified associations between certain DNA modifications and increased risks of breast cancer, type II diabetes, and chronic obstructive pulmonary disease (COPD). The findings provide new insights into the underlying mechanisms of these diseases.
COPD patients treated with dupilumab experienced rapid and sustained improvements in disease, as measured by reduced acute exacerbations, better lung function, and improved quality of life. This is the first biologic to show clinical outcomes improvement in COPD.
The June issue of CHEST features 49 articles on clinically relevant topics, including asthma, COPD, and critical care. The journal offers web and multimedia resources to expand the reach of its research.
A recent Finnish register-based study found no association between inhaled beta-2 agonist use and reduced risk of Parkinson's disease. Accumulation of alpha-synuclein protein is a key factor in the disease. The study controlled for age, sex, and comorbidities to rule out confounding factors.
Researchers at Texas Biomedical Research Institute have developed a new cell culture model to generate human alveolar macrophages, the most critical immune cells in the lungs. This model allows for easier and inexpensive investigation of lung inflammatory diseases and testing of new therapies.
A large-scale registry study found that older autistic adults have a significantly higher risk of injury, especially self-inflicted, and physical conditions such as type 2 diabetes and anaemia. Autistic individuals had a seven-fold risk of self-harm compared to non-autistic people.
Researchers have identified potential targets for COPD treatment through high-resolution epigenetic profiling of lung fibroblasts. Early epigenetic changes in the genome of COPD fibroblasts may trigger aberrant signaling pathways leading to impaired functions, suggesting new therapeutic avenues.
Researchers found that COPD patients prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) like zolpidem did not have increased risk of hospitalizations or death compared to those prescribed other types of hypnotics. However, they had a greater risk of death and exacerbations when not prescribed hypnotic drugs
The COPDGene study tracked emphysema patients over 10 years and found that those who continued to smoke experienced the largest decline in lung density. This significant finding highlights the importance of quitting smoking in managing emphysema progression, particularly for current smokers.
A retrospective analysis of patient data suggests that targeting mucus plugs in the lungs may help prevent deaths from COPD. The study found that patients with mucus plugs had a higher mortality rate compared to those without, with significant associations across different disease phases.
Researchers found variant cells in lungs of IPF patients that can drive fibrosis and inflammation. These cells may be targeted for future therapy, offering new hope for treatment.
The May issue of the CHEST journal features cutting-edge research on pulmonary, critical care, and sleep medicine. The journal also highlights awareness for cystic fibrosis, a once-fatal childhood condition now affecting adults.
The American Thoracic Society International Conference Abstracts publication features selected abstracts on COPD treatment, including a study on improving depression through home-based pulmonary rehabilitation. The issue also highlights recent findings on sleep apnea severity, as well as research on health equity and access to care.